267 related articles for article (PubMed ID: 31065546)
21. Influenza vaccines: challenges and solutions.
Houser K; Subbarao K
Cell Host Microbe; 2015 Mar; 17(3):295-300. PubMed ID: 25766291
[TBL] [Abstract][Full Text] [Related]
22. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
23. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
24. Vaccine approaches conferring cross-protection against influenza viruses.
Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adults.
Chou CH; Mohanty S; Kang HA; Kong L; Avila-Pacheco J; Joshi SR; Ueda I; Devine L; Raddassi K; Pierce K; Jeanfavre S; Bullock K; Meng H; Clish C; Santori FR; Shaw AC; Xavier RJ
Aging Cell; 2022 Sep; 21(9):e13682. PubMed ID: 35996998
[TBL] [Abstract][Full Text] [Related]
26. Inactivation methods for whole influenza vaccine production.
Sabbaghi A; Miri SM; Keshavarz M; Zargar M; Ghaemi A
Rev Med Virol; 2019 Nov; 29(6):e2074. PubMed ID: 31334909
[TBL] [Abstract][Full Text] [Related]
27. Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature.
Dini G; Toletone A; Sticchi L; Orsi A; Bragazzi NL; Durando P
Hum Vaccin Immunother; 2018 Mar; 14(3):772-789. PubMed ID: 28787234
[TBL] [Abstract][Full Text] [Related]
28. The threat of human influenza: the viruses, disease impacts, and vaccine solutions.
Yin JK; Salkeld G; Heron L; Khandaker G; Rashid H; Booy R
Infect Disord Drug Targets; 2014; 14(3):150-4. PubMed ID: 25313099
[TBL] [Abstract][Full Text] [Related]
29. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
[TBL] [Abstract][Full Text] [Related]
30. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.
Wang TT; Bournazos S; Ravetch JV
Curr Opin Immunol; 2018 Aug; 53():124-129. PubMed ID: 29753885
[TBL] [Abstract][Full Text] [Related]
31. Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
Howard LM; Hoek KL; Goll JB; Samir P; Galassie A; Allos TM; Niu X; Gordy LE; Creech CB; Prasad N; Jensen TL; Hill H; Levy SE; Joyce S; Link AJ; Edwards KM
PLoS One; 2017; 12(1):e0167488. PubMed ID: 28099485
[TBL] [Abstract][Full Text] [Related]
32. The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients.
Scanlon N; Saklawi Y; Rouphael N
Front Immunol; 2020; 11():582201. PubMed ID: 33324400
[TBL] [Abstract][Full Text] [Related]
33. New Approaches to Vaccinology Made Possible by Advances in Next Generation Sequencing, Bioinformatics and Protein modeling.
Woolums AR; Swiderski C
Curr Issues Mol Biol; 2021; 42():605-634. PubMed ID: 33627518
[TBL] [Abstract][Full Text] [Related]
34. Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza?
Rambhia KJ; Rambhia MT
Clin Infect Dis; 2019 Mar; 68(7):1235-1240. PubMed ID: 30169619
[TBL] [Abstract][Full Text] [Related]
35. Influenza Virus: Dealing with a Drifting and Shifting Pathogen.
Kim H; Webster RG; Webby RJ
Viral Immunol; 2018 Mar; 31(2):174-183. PubMed ID: 29373086
[TBL] [Abstract][Full Text] [Related]
36. Influenza vaccines: a moving interdisciplinary field.
Schotsaert M; García-Sastre A
Viruses; 2014 Oct; 6(10):3809-26. PubMed ID: 25302957
[TBL] [Abstract][Full Text] [Related]
37. Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine.
Coughlan L; Palese P
Cell Host Microbe; 2018 Jul; 24(1):18-24. PubMed ID: 30001520
[TBL] [Abstract][Full Text] [Related]
38. Systems Immunology: Revealing Influenza Immunological Imprint.
Tomic A; Pollard AJ; Davis MM
Viruses; 2021 May; 13(5):. PubMed ID: 34065617
[TBL] [Abstract][Full Text] [Related]
39. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
40. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
